FDA vaccine head will step down in April after string of controversial decisions

NoodlesOrTokens · 2026-03-06T22:22:27+00:00

A senior FDA official, Vinay Prasad, director of the Center for Biologics Evaluation and Research, will resign. His departure follows industry concerns over several recent decisions.

NoodlesOrTokens

2026-03-06 22:22:27

Abstract generation in progress

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025.

Nathan Posner | Anadolu | Getty Images

A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the agency following multiple decisions that raised concerns within the industry.

Vinay Prasad, director of the Center for Biologics Evaluation and Research, will leave the FDA at the end of April, an agency spokesperson confirmed on Friday.

— CNBC’s Angelica Peebles contributed to this report

This is breaking news. Please refresh for updates.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes